Bridgeway Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $256K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $164K | Hold |
|
|||||
|
2024
Q2 | $275K | Hold |
|
|||||
|
2024
Q1 | $199K | Sell |
|
|||||
|
2023
Q4 | $314K | Hold |
|
|||||
|
2023
Q3 | $483K | Hold |
|
|||||
|
2023
Q2 | $510K | Buy |
|
|||||
|
2023
Q1 | $605K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $31K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $477K | Sell |
|
|||||
|
2019
Q4 | $555K | Buy |
|
|||||
|
2019
Q3 | $119K | Hold |
|
|||||
|
2019
Q2 | $122K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $778K | Sell |
|
|||||
|
2018
Q2 | $994K | Hold |
|
|||||
|
2018
Q1 | $764K | Buy |
|
|||||
|
2017
Q4 | $245K | Hold |
|
|||||
|
2017
Q3 | $456K | Hold |
|
|||||
|
2017
Q2 | $497K | Buy |
|